Qube Research & Technologies LTD Verrica Pharmaceuticals Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 35,262 shares of VRCA stock, worth $280,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,262
Previous 322,186
89.06%
Holding current value
$280,332
Previous $2.56 Million
89.07%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VRCA
# of Institutions
79Shares Held
26.1MCall Options Held
9.9KPut Options Held
6.5K-
Armistice Capital, LLC New York, NY8.92MShares$70.9 Million1.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.25MShares$25.8 Million0.86% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.59MShares$20.6 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$14.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...